News
AZ, Sanofi's Beyfortus gets CDC okay for RSV prevention
The final obstacle to the routine use of Sanofi and AstraZeneca's Beyfortus to prevent respiratory syncytial virus (RSV) in the US has fallen after it was backed by Centre
